000 01526 a2200433 4500
005 20250513232615.0
264 0 _c20010426
008 200104s 0 0 eng d
022 _a0014-5793
024 7 _a10.1016/s0014-5793(01)02166-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHögnason, T
245 0 0 _aEpidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling.
_h[electronic resource]
260 _bFEBS letters
_cFeb 2001
300 _a9-15 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aApoptosis
650 0 4 _aBlotting, Western
650 0 4 _aEpidermal Growth Factor
_xmetabolism
650 0 4 _aErbB Receptors
_xgenetics
650 0 4 _aGenes, Dominant
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aPhosphorylation
650 0 4 _aProtein Serine-Threonine Kinases
650 0 4 _aProtein-Tyrosine Kinases
_xgenetics
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-akt
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTumor Cells, Cultured
700 1 _aChatterjee, S
700 1 _aVartanian, T
700 1 _aRatan, R R
700 1 _aErnewein, K M
700 1 _aHabib, A A
773 0 _tFEBS letters
_gvol. 491
_gno. 1-2
_gp. 9-15
856 4 0 _uhttps://doi.org/10.1016/s0014-5793(01)02166-4
_zAvailable from publisher's website
999 _c11164164
_d11164164